Patents by Inventor Gerald R. Fitzgerald

Gerald R. Fitzgerald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inactivated Mycolplasma hyopneumoniae and uses therefor
    Patent number: 5968525
    Abstract: The invention relates to a method for making an inactivated vaccine of Mycoplasma hyopneumoniae by inactivating the bacteria with Thimerosal. The resulting bacterin is mixed with an adjuvant of aluminum hydroxide and DEAE dextran and injected into pigs. The resulting bacterin and adjuvant mixture can also be mixed with other bacteria such as Bordetella and Pasteurella, for further adjuvant effect. Protective immunity against mycoplasmal pneumonia is elicited in swine using these vaccines.
    Type: Grant
    Filed: January 2, 1998
    Date of Patent: October 19, 1999
    Assignee: Ambico, Inc.
    Inventors: Gerald R. Fitzgerald, C. Joseph Welter
  • Thimerosal inactivated mycoplasma hyopneumoniae vaccine
    Patent number: 5338543
    Abstract: The invention relates to a method for making an inactivated vaccine of Mycoplasma hyopneumoniae by inactivating the bacteria with Thimerosal. The resulting bacterin is mixed with an adjuvant of aluminum hydroxide and DEAE dextran and injected into pigs. The resulting bacterin and adjuvant mixture can also be mixed with other bacteria such as Borderella and Pasteurella, for further adjuvant effect. Protective immunity against mycoplasmal pneumonia is elicited in swine using these vaccines.
    Type: Grant
    Filed: May 29, 1992
    Date of Patent: August 16, 1994
    Assignee: Ambico, Inc.
    Inventors: Gerald R. Fitzgerald, C. Joseph Welter
  • Inactivated mycoplasma hyopneumoniae and uses therefor
    Patent number: RE39494
    Abstract: The invention relates to a method for making an inactivated vaccine of Mycoplasma hyopneumoniae by inactivating the bacteria with Thimerosal. The resulting bacterin is mixed with an adjuvant of aluminum hydroxide and DEAE dextran and injected into pigs. The resulting bacterin and adjuvant mixture can also be mixed with other bacteria such as Bordetella and Pasteurella, for further adjuvant effect. Protective immunity against mycoplasmal pneumonia is elicited in swine using these vaccines.
    Type: Grant
    Filed: August 5, 2004
    Date of Patent: February 27, 2007
    Assignee: Intervet Inc.
    Inventors: Gerald R. Fitzgerald, C. Joseph Welter